Rheumatic Disease Clinics of North America

Article	Citations
Copyright	107
Contents	64
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	45
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	35
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network	33
Osteoarthritis Treatment Guidelines from Six Professional Societies	30
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	21
Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases	19
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	17
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	16
Copyright	16
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	15
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	14
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	13
Artificial Intelligence in Musculoskeletal Imaging	13
Forthcoming Issues	13
COPA Syndrome from Diagnosis to Treatment	13
Lessons Learned from the COVID-19 Pandemic in Rheumatology	12
The Short and Long of COVID-19	12
Taxonomy of Quality of Care Indicators	12
Contributors	11
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	11
Copyright	10
Contributors	10
Imaging Challenges and Developments in Large-vessel Vasculitis	10

Expanding the Treatment Team	9
Pulmonary Hypertension Associated with Connective Tissue Disease	9
Copyright	9
De novo Connective Tissue Disorders as Immune-related Adverse Events	9
Contents	9
Primary Cardiac Involvement in Systemic Sclerosis	8
Newer Immunosuppressants for Rheumatologic Disease	8
Daniel J McCarty, MD: A Giant of Rheumatology	8
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	8
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	8
Scleroderma: Best Approaches to Patient Care	7
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	7
Preventative Care in Scleroderma	7
COVID-19 and Rheumatology	7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	7
Charles L Christian	7
Cardiac MRI in Rheumatic Disease	6
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	6
Copyright	6
Imaging of Pulmonary Manifestations of Connective Tissue Disease	6
Sustainable Health Care and Advocacy for Rheumatologists	6
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	6
E Carwile LeRoy, MD	6
Contributors	6
A Guide to Contemporary Clinical Practice Guidelines	5
Global Rheumatology	5
Heart Failure in Rheumatic Disease	5
Contents	5
The Challenges of New Biologic Therapies in Pediatrics	5
Guideline Development and Implementation in Rheumatic Disease	5
Imaging of the Major Salivary Glands in Rheumatic Disease	5
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies	5
Forthcoming Issues	4
Copyright	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Impacts of Storms, Precipitation, Drought, and Water Quality on Rheumatic Diseases	4
Contents	4
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	4
Myositis	4
Contributors	4
Beyond Coronary Artery Disease	4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	3
The Role of Psychology in Pediatric Rheumatic Diseases	3
Dual-Energy Computed Tomography Applications in Rheumatology	3
Health Care Utilization	3
Emerging and Expanding Infections due to Climate Change of Concern to Rheumatologists	3
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	3
Treatment Guidelines in Gout	3
SARS-CoV-2 Infection and COVID-19 in Children	3

Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	3
Achieving Precision Medicine in Psoriatic Arthritis	3
Copyright	3
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	3
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis	3
Expanding IPEX: Inborn Errors of Regulatory T Cells	3
Forthcoming Issues	2
Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus	2
Impact of Climate Change on Rheumatology Care	2
Interstitial Lung Disease	2
Training the Next Generation of Rheumatologists	2
Emerging Treatment Options for Inclusion Body Myositis	2
Myositis in 2025: Defining Subtypes, Closing Gaps, and Shaping the Future	2
Imaging in Inflammatory Bowel Disease	2
Contents	2
Diagnostic Evaluation for Myositis and Their Pitfalls	2
Imaging in Juvenile Idiopathic Arthritis	2
Forthcoming Issues	2
Forthcoming Issues	2
The GRADE Method	2
The Effects of Extreme Heat on Individuals with Rheumatic Conditions	2
Rheumatology Care in an Aging World	2
Forthcoming Issues	2
Gerald P Rodnan	1
Treatment Guidelines in Vasculitis	1
Forthcoming Issues	1
Targeting Environmental Risks to Prevent Rheumatic Disease	1
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	1
Systemic Diseases and Heart Block	1
Treatment of Vascular Complications in Systemic Sclerosis	1
Foreword	1
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis	1
Targeted Treatment of Diseases of Immune Dysregulation	1
Preface	1
Axial Imaging in Spondyloarthritis	1
Cardiovascular Disease in Large Vessel Vasculitis	1
Pesticides, Rheumatic Diseases, and Emerging Environmental Threats	1
Forthcoming Issues	1
Treatment of Inflammatory Arthritis in Systemic Sclerosis	1
Rheumatology at the Threshold of Artificial Intelligence	1
Contributors	1
Patient-Reported Outcomes in Myositis	1
Copyright	1
Vasculitis	1
Foreword	1
Long COVID for the Rheumatologist	1
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis	1
The Giants Of Rheumatology	1
Artificial Intelligence Regulation in the United States	1
Foreword	1
The Current and Future of Biomarkers of Immune Related Adverse Events	1
Nathan Zvaifler	1
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis	1
J. Claude Bennett, MD	1
Impact of Stress and Eco-anxiety on Rheumatic Disease	1
Contributors	1
Foreword	1
The Mythology of Polymyositis	1
Forthcoming Issues	1
Highlights of Interdisciplinary Care in Rheumatology	1
Imaging in Rheumatology	1
Climate Change, Pollution, and Sustainability	1
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease	0
New and Emerging Rheumatic Diseases	0
Contributors	0
Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis	0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases	0
Challenges in Developing Treatment Guidelines in Psoriatic Arthritis	0
Scleroderma: Best Approaches to Patient Care	0
Foreword	0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis	0
Climate Change, Pollution, and Sustainability in Rheumatic Diseases	0
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease	0
Systemic Lupus Erythematosus Risk	0
Contents	0
Epidemiologic Opportunities and Challenges in Studying Environmental Risk Factors for Rheumatic Diseases	0
Isolated Aortitis	0
Contributors	0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology	0

Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:	0
Environmental Risks for Systemic Sclerosis	0
Foreword	0
Lessons from Carl M. Pearson 1919 – 1981	0
Contributors	0
Newer Immunosuppressants for Rheumatologic Disease	0
The Future of Vasculitis	0
Cardiovascular Complications of Chronic Rheumatic Diseases	0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis	0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases	0
Patient Experience of Systemic Sclerosis–Related Calcinosis	0
Environmental Risks for Inflammatory Myopathies	0
Food as Medicine for Rheumatic Diseases and Planetary Health	0
Contents	0
Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology	0
Suppressor of Cytokine Signaling 1 Haploinsufficiency	0
Preventative Care in Scleroderma	0
Forthcoming Issues	0
Forthcoming Issues	0
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination	0
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases	0
Rheumatology Care Among Indigenous Populations	0
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis	0
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases	0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients	0
Updates in Ultrasound in Rheumatology	0
Physical Activity for Human and Planetary Health	0
Emerging Concepts in Immune Dysregulation	0
Rheumatic Immune-related Adverse Events	0
Eric Bywaters and Barbara Ansell	0
Copyright	0
Copyright	0
Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases	0
Contributors	0
Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology	0
Vasculitis	0
Contributors	0
Axial Psoriatic Arthritis	0
Copyright	0
Emerging Concepts in the Diagnosis and Treatment of Systemic Vasculitis	0
Management of Lung Manifestations in Idiopathic Inflammatory Myopathies	0
Foreword	0
Giant Cell Arteritis and Polymyalgia Rheumatica	0
It Takes a Village	0
The Future of Rheumatology Leadership in Africa	0
Emerging Concepts in Immune Dysregulation	0
Environmental Triggers for Vasculitis	0
Environmental Triggers for Rheumatic Diseases	0
Contents	0
Vasculitis Mimics and Other Related Conditions	0
How the American College of Rheumatology Develops Guidelines	0
Copyright	0
Contributors	0
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy	0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders	0
Imaging in Rheumatology	0
Environmental Triggers for Rheumatic Diseases	0
Copyright	0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases	0
Calcinosis in Adult and Juvenile Dermatomyositis	0
Lessons on Telemedicine in Rheumatology	0
Mental Health Considerations in Chronic Disease	0
Contents	0
New Developments in Imaging in Crystalline Arthritis	0
Contents	0
Central Nervous System Vasculitis	0
Interventions to Improve COVID-19 Vaccine Hesitancy	0
Gastrointestinal Tract Considerations: Part II	0
Naomi Rothfield, MD, MACR	0
NF-κB and Related Autoimmune and Autoinflammatory Diseases	0
Forthcoming Issues	0
Best Approaches to the Care of Systemic Sclerosis Patients	0
Updates in the Management of Immune-Mediated Necrotizing Myopathy	0
Prospects of Disease-Modifying Osteoarthritis Drugs	0
Persistent Gaps in Global Rheumatology Care and Research	0
Vasculitis and Pregnancy	0
Environmental Risks for Spondyloarthropathies	0
Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights	0
Contributors	0
Psoriatic Arthritis Updates	0
Guideline Development and Implementation in Rheumatic Disease	0
Forthcoming Issues	0
Imaging of Rheumatic Diseases Affecting the Lower Limb	0
Climate Change and the Exposome in Autoimmune Rheumatic Diseases	0
Contents	0
Immunotherapy Toxicity Management in Clinical Practice	0
Imaging Revolutions in Modern Rheumatology	0
Integrative Rheumatology	0
Forthcoming Issues	0
Forthcoming Issues	0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	0
Coronavirus Disease-2019 in the Immunocompromised Host	0
Type I Interferonopathies	0
Overview of Climate Change, Pollution, and Sustainability in the Rheumatic and Autoimmune Diseases	0
Scleroderma Skin	0